The Committee was informed of the wide diversity of relevant training activities in which WHO, through its Division of Drug Management and Policies, had been involved. These activities include the following:
• Individual training in drug regulatory agencies in more advanced countries.
• Regional training seminar on the technical assessment of dossiers for marketing authorization, organized by the German Foundation for International Development (DSE).
• Seminar on quality assurance for drug regulators, organized by the International Federation of Pharmaceutical Manufacturers Association (IFPMA).
• Individual training for analysts and inspectors, offered by the IFPMA and the World Federation of Proprietary Medicine Manufacturers.
• Regional seminar on GMP, organized by FIP in cooperation with the West African Pharmaceutical Federation.
• Training in the use of the WHO model package designed to support computer-assisted drug registration.
• The 12-month Master of Science course in pharmaceutical services and medicines control, Bradford, England, targeted primarily at pharmacists working in the public sector in developing countries and also at the newly independent States of the former Soviet Union.
WHO's Regional Offices and its Action Programme on Essential Drugs are involved in training activities for drug regulators, often through the relevant WHO Collaborating Centres.
The Committee was also informed about a recently created one-year university programme on the development and international registration of medicines at the Faculty of Pharmacy of the University of Paris-Sud, France.